[Symptomatic treatment of benign hypertrophy of the prostate. Comparative study of prazosin and serenoa repens].
Forty-five patients diagnosed as having BPH and clinically diagnosed micturition disorders were entered in a therapeutic protocol. Twenty-five patients received Prazosin and the remaining 20 patients were treated with Serenoa Repens for a period of 12 weeks. The symptomatology was assessed by flowmetry and the patients were questioned as to the irritative symptoms. It can be concluded from the study that Prazosin is slightly more effective in controlling the irritative symptoms produced by BPH.
Adriazola Semino
M
M
Servicio de Urología, Hospital Río Carrión, Palencia, España.
Lozano Ortega
J L
JL
García Cobo
E
E
Tejeda Báñez
E
E
Romero Rodríguez
F
F
D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D008297:Male; D008875:Middle Aged; D010936:Plant Extracts / Q000494:pharmacology / Q000627:therapeutic use*; D011224:Prazosin / Q000494:pharmacology / Q000627:therapeutic use*; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000503:physiopathology; D028024:Serenoa; D014554:Urination / Q000187:drug effects
D010936:Plant Extracts; C040972:saw palmetto extract; D011224:Prazosin